
Bexagliflozin
CAS No. 1118567-05-7
Bexagliflozin( THR-1442 | EGT-1442 )
Catalog No. M10426 CAS No. 1118567-05-7
A potent and selective SGLT2 inhibitor with IC50 of 2 nM; shows little activity for SGLT1 (IC50=5.6 uM).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 83 | In Stock |
![]() ![]() |
5MG | 124 | In Stock |
![]() ![]() |
10MG | 186 | In Stock |
![]() ![]() |
25MG | 372 | In Stock |
![]() ![]() |
50MG | 552 | In Stock |
![]() ![]() |
100MG | 786 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameBexagliflozin
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective SGLT2 inhibitor with IC50 of 2 nM; shows little activity for SGLT1 (IC50=5.6 uM).
-
DescriptionA potent and selective SGLT2 inhibitor with IC50 of 2 nM; shows little activity for SGLT1 (IC50=5.6 uM); produces a saturable urinary glucose excretion in normal rats and dogs with ED50 of 0.38 and 0.09mg/kg, respectively; reduced HbA(1c) and blood glucose concentration without affecting body mass or insulin level in db/db mice.Diabetes Phase 3 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsTHR-1442 | EGT-1442
-
PathwayGPCR/G Protein
-
TargetSGLT
-
RecptorSGLT
-
Research AreaMetabolic Disease
-
IndicationDiabetes
Chemical Information
-
CAS Number1118567-05-7
-
Formula Weight464.9359
-
Molecular FormulaC24H29ClO7
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESOC[C@@H](O1)[C@@H](O)[C@H](O)[C@@H](O)C1C2=CC(CC(C=C3)=CC=C3OCCOC4CC4)=C(Cl)C=C2
-
Chemical NameD-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[2-(cyclopropyloxy)ethoxy]phenyl]methyl]phenyl]-, (1S)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wang L, et al. Xenobiotica. 2016 Aug;46(8):703-8.
2. Zhang W, et al. Pharmacol Res. 2011 Apr;63(4):284-93.
molnova catalog



related products
-
Quinine HCl Dihydrat...
Quinine HCl Dihydrate is a white crystalline K+ channel blocker, used to treat malaria.
-
YM543
A potent, selective and orally active SGLT2 inhibitor with IC50 of 8.9 nM, 280-fold selectivity over SGLT1.
-
T-1095
T-1095 is an inhibitor of renal glucose reabsorption and the expression of Na+-glucose cotransporters (SGLTs) and facilitative glucose transporter 2 (GLUT2).